JENKEM TECHNOLOGY CO LTD TIANJIN has a total of 11 patent applications. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are MEDHERANT LTD, CONTROLLED THERAPEUTICS SCT and CONTROLLED THERAPEUTICS SCOTLAND LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Australia | 1 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Macromolecular chemistry and polymers |
# | Name | Total Patents |
---|---|---|
#1 | Zhao Xuan | 10 |
#2 | Feng Zewang | 8 |
#3 | Xu Lihua | 5 |
#4 | Wang Zhenguo | 4 |
#5 | Guo Zhixiong | 3 |
#6 | Wang Jinliang | 2 |
#7 | Chen Xiaomeng | 2 |
#8 | Liu Yan | 2 |
#9 | Lin Meina | 2 |
#10 | Huang Wenzhe | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015081830A1 | Stearic acid derivatives and oleic acid derivatives of multi-arm polyethylene glycol | |
WO2014201856A1 | Dasatinib and nonlinear configuration polyethylene glycol conjugate | |
WO2014190763A1 | Low molecular weight polyethylene glycol drug conjugates having improved drug biological activity | |
EP2818169A1 | Conjugate of polyethylene glycol and naloxone, pharmaceutical composition and use thereof | |
WO2013078769A1 | Conjugate of polyethylene glycol and tamsulosin and pharmaceutical composition thereof |